搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
19 小时
Investors Slaughter Q32 Bio On A 'Messy' Update In Eczema, Alopecia Treatment
Q32 Bio delivered a "messy" update for its eczema and alopecia treatment, leading the biotech stock to collapse to a record ...
22 小时
AnaptysBio to abandon eczema drug development after mid-stage trial failure
AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a ...
1 天
The best moisturisers for eczema, according to experts
Eczema-prone skin needn't mean a mundane moisturiser; our edit includes the ingredient-led, the fragranced and the luxurious ...
6 天
Relief for eczema flare-ups: How to manage symptoms if your skin condition worsens
When conventional treatments for moderate to severe atopic dermatitis become less effective, targeted therapies may help.
Onlymyhealth
1 天
Try THIS If You Have Eczema Or Psoriasis
Managing eczema or psoriasis requires a wide approach Hence by focusing on sugar control a high-protein diet and incorporating diluted apple cider vinegar you can take meaningful steps toward healthie ...
1 天
Unmet needs in the chronic hand eczema treatment landscape
Chronic exposure to irritants, allergens, and repetitive hand washing are established risk factors for chronic hand eczema.
2 天
Scratching the Surface: New Insights into Eczema Itch
Researchers believe they’ve discovered the hidden culprit behind eczema itch, paving the way for groundbreaking new treatment ...
来自MSN
1 天
4 things to know about eczema
Atopic dermatitis, commonly known as eczema, is a chronic skin condition that affects roughly one in five Canadians at some ...
1 天
Nara Smith opens up about her struggles with chronic skin condition eczema
Famed for her incredible IG cook-a-longs, model Nara Smith has been opening up about her battles with skin condition eczema.
clinicaltrialsarena
3 小时
AnaptysBio’s atopic dermatitis trial of BTLA agonist misses endpoints
AnaptysBio has reported that the ARISE-AD trial of ANB032, for treating moderate-to-severe atopic dermatitis failed to meet both endpoints.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈